Exit Mode
CompletedHealthcare19 May 2026

Nexalin Technology, Inc. to acquire PONM, Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Nexalin Technology, Inc.
Target
PONM, Inc.
Deal value
USD 1,300,000
Announced
19 May 2026
Status
Completed
Sector
Healthcare
Country
United States
Consideration
shares

Sources

SEC_EDGAR_8K
What we know

Nexalin Technology, Inc. has agreed to acquire PONM, Inc. in a strategic acquisition within the Healthcare sector. The transaction, valued at 1.3 million USD, was settled entirely through the exchange of shares. Both the acquiring entity and the target company are based in the United States, creating a domestic consolidation of assets in the medical technology space. The deal was announced on 19 May 2026, following its completion on 14 May 2026, indicating a rapid execution of the agreement between the two parties.

The consideration structure relies solely on equity, suggesting a focus on long-term alignment between the combined entities. As a strategic acquisition, this move integrates the capabilities of PONM, Inc. into the broader portfolio of Nexalin Technology, Inc. without the involvement of external debt or cash outlays. The transaction has now reached its final stage, with all necessary conditions for the transfer of ownership satisfied. The transaction is subject to regulatory approval.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. CompletedClosed

    Nexalin Technology, Inc. completes acquisition of PONM, Inc.

    Item 1.01 Entry into a Material Definitive Agreement. Stock Purchase Agreement On May 14, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GreenLight Ventures LLC, a North Carolina limited liability company (“GLV”). Pursuant to the Purchase Agreement, the Company purchased from GLV, 100 shares (the “PONM Shares”) of common stock

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare dealsMore 2026 dealsMore strategic acquisition dealsMore from Nexalin Technology, Inc.All M&A deals

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Nexalin Technology, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive
Get the Exit Mode Toolkit, $97